- Previous Close
25.31 - Open
23.01 - Bid 23.01 x --
- Ask --
- Day's Range
23.01 - 23.01 - 52 Week Range
15.60 - 25.31 - Volume
821,017 - Avg. Volume
1,863,145 - Market Cap (intraday)
5.325B - Beta (5Y Monthly) 0.20
- PE Ratio (TTM)
30.93 - EPS (TTM)
0.90 - Earnings Date --
- Forward Dividend & Yield 0.70 (2.77%)
- Ex-Dividend Date Jan 21, 2025
- 1y Target Est
--
Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients. It operates through Pharmaceutical Industry, Pharmaceutical Wholesale and Distribution, and Pharmaceutical Retail Business segments. The company offers active pharmaceutical ingredients, which include nifedipine, paliperidone, prilocaine, methylphenidate hydrochloride, dimercaptosuccinic acid, doxazosin mesylate, paeonol, urea, felodipine, and troxerutin; and medical preparations, such as osmotic pump preparations, central nervous systems, Chinese patent medicines, eye drops, external use, and general oral medicines. In addition, it provides medical intermediates, including 3-methoxy-1 propanethiol, mercaptosuccinic acid, domiphene, sodium dimercaptosulfonate, 3-mercapto-1-propanol, paeonol, sodium paeonol sulfonate, methyl 2,3-dichlorobenzylidene acetoacetate, n-[(1,4-benzodioxan-2-yl) carbonyl piperazine hydrochloride, alogliptin benzoate, roflumilast, and zofenopril calcium; plant extract products, such as clove oil and campanula extracts; and pieces that consist of poria decoction, astragalus, honeysuckle, rose, and phellinus decoction. Further, the company offers central nervous system drugs, cardiovascular drugs, digestive system drugs, ophthalmic drugs, external skin drugs and other fields. Hefei Lifeon Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Hefei, China.
www.lifeonapi.comRecent News: 003020.SZ
View MorePerformance Overview: 003020.SZ
Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 003020.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 003020.SZ
View MoreValuation Measures
Market Cap
4.84B
Enterprise Value
4.42B
Trailing P/E
28.02
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.24
Price/Book (mrq)
2.80
Enterprise Value/Revenue
2.95
Enterprise Value/EBITDA
22.17
Financial Highlights
Profitability and Income Statement
Profit Margin
11.61%
Return on Assets (ttm)
4.37%
Return on Equity (ttm)
9.61%
Revenue (ttm)
1.5B
Net Income Avi to Common (ttm)
174.28M
Diluted EPS (ttm)
0.90
Balance Sheet and Cash Flow
Total Cash (mrq)
487.65M
Total Debt/Equity (mrq)
3.58%
Levered Free Cash Flow (ttm)
44.96M